series. The second and third doses should be separated by at least 2 months’ interval. 
x If the HCW has had two series of the HBV vaccine and was still a non-responder, they 
should receive a second dose of HBIG, 1 month after the ﬁ  rst dose.
x Following completion of three-dose vaccination series, the level of immunity (antibodies 
to surface antigen, i.e. anti-HBs titres) should be checked 1–2 months later. Those whose anti-HBs titres are <10 mIU/ml should complete a second three-dose vaccine series or be evaluated for HBsAg positivity. If HBsAg is positive after exposure, the person should be counselled regarding the modes of prevention of HBV transmission to others and to seek treatment for HBV.
Table 1.  Post-exposure prophylaxis for percutaneous or per mucosal exposure to